Neurology

One-third of early PD patients show cognitive decline

 

A longitudinal study has examined cognitive decline in 106 patients with early Parkinson’s disease (mean age 61.2 years). Cognitive decline was assessed using the Mini Mental State Examination (MMSE; mean baseline 27.8) (Kandiah et al. Mov Disord 2009); epublished February 3, 2009.  

Read More

TOPICS:

Viral reactivation with natalizumab

 

The clinical use of the alpha-4 integrin antagonist natalizumab may be associated with reactivation of other viruses, according to a study conducted in Ireland (Lonergan et al. J Neurovirol 2009; epublished August 9, 2009).

Read More

TOPICS:

CIHR, Quebec and France collaborate on Alzheimer disease research

 

The Canadian Institutes of Health Research (CIHR, www.cihr-irsc.gc.ca), in conjunction with the province of Quebec and France, has launched a new funding program for innovative projects in Alzheimer’s disease research. CIHR will commit $600,000, Quebec $800,000 and France $1.1 million over the next three years to the program. A joint request for applications is currently being developed.

Read More

TOPICS: